Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. (2021)

First Author: Jonasch E
Attributed to:  Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2103425

PubMed Identifier: 34818478

Publication URI: http://europepmc.org/abstract/MED/34818478

Type: Journal Article/Review

Volume: 385

Parent Publication: The New England journal of medicine

Issue: 22

ISSN: 0028-4793